The "other" signaling of trastuzumab: antibodies are immunocompetent drugs

J Clin Oncol. 2008 Apr 10;26(11):1778-80. doi: 10.1200/JCO.2007.15.7404. Epub 2008 Mar 17.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Disease-Free Survival
  • Female
  • Humans
  • Receptors, Fc / metabolism*
  • Signal Transduction
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptors, Fc
  • Trastuzumab